UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Startups to Watch]‘Big data will determine pharmaceutical industry’s future’
“Korea drugmakers can make giant leaps with big data.”Yi Hong-gi, CEO of Co...
by Lee Han-soo
|
2017-12-08 11:46
라인
JW CreaGene starts clinical trial for glioblastoma treatment
JW CreaGene, a subsidiary of JW Shinyak, said Thursday that it has started ...
by Lee Han-soo
|
2017-12-07 15:19
라인
Celltrion seeks to shift to main bourse
Biosimilar maker Celltrion is aiming to relist its stocks on the Korea Exch...
by Lee Han-soo
|
2017-12-07 11:25
라인
Humedix opens 2nd factory in Jecheon
Huons Global Vice Chairman Yoon Sung-tae (center) and other executives and ...
by Lee Han-soo
|
2017-12-06 16:49
라인
Medipost wins patent for Cartistem in Europe
Medipost said Wednesday that it has acquired patents on its core production...
by Lee Han-soo
|
2017-12-06 13:15
라인
Daewoong denies defeat in suit against Korea United
Daewoong Pharmaceutical said Tuesday that the recent dismissal of the paten...
by Lee Han-soo
|
2017-12-05 16:13
라인
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo
|
2017-12-05 15:40
라인
Access Bio signs accord to supply malaria kit
Access Bio said Tuesday that it has signed an agreement with Chemonics and ...
by Lee Han-soo
|
2017-12-05 10:52
라인
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo
|
2017-12-04 16:17
라인
Nature Cell’s clinical trial on Alzheimer therapy running smoothly
Nature Cell said Monday that it has injected 10 doses of Astrostem, a stem-...
by Lee Han-soo
|
2017-12-04 14:57
라인
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment
Pharmicell said Monday that the U.S. Food and Drug Administration has appro...
by Lee Han-soo
|
2017-12-04 14:57
라인
Agency releases interim epidemiologic survey on past hepatitis C outbreak
JS Clinic opened after the Seoul Hyeondae Clinic closed in 2014. Although t...
by Lee Han-soo
|
2017-12-01 18:26
라인
Europe suspends sales of certain MRI contrast agent products
The European Commission has suspended the sale of certain products for intr...
by Lee Han-soo
|
2017-12-01 15:47
라인
FDA okays opioid use disorder treatment
The U.S. Food and Drug Administration (FDA) said Thursday that it has appro...
by Lee Han-soo
|
2017-12-01 13:59
라인
Panagene wins patent for molecular diagnostic platform
Panagene said Thursday that it has completed its patent registration for PA...
by Lee Han-soo
|
2017-12-01 11:02
라인
Medidata introduces new Strategic Monitoring solution
Medidata said Thursday that it has launched Strategic Monitoring solution t...
by Lee Han-soo
|
2017-12-01 11:02
라인
Ministry finalizes selection of regional trauma centers
The Ministry of Health and Welfare said Wednesday that it has finalized its...
by Lee Han-soo
|
2017-11-30 17:30
라인
Medipost hits record vial sales for Cartistem
Medipost said Thursday that it hit record sales of 266 vials for Cartistem,...
by Lee Han-soo
|
2017-11-30 16:16
라인
FDA setting up new guidelines to boost complex generic drug development
Scott Gottlieb, the commissioner of the U.S. Food and Drug Administration (...
by Lee Han-soo
|
2017-11-30 10:28
라인
‘Healthcare workforce crucial to world development’
John MacArthur, director of the U.S. Centers for Disease Control and Preven...
by Lee Han-soo
|
2017-11-29 16:55
-
이전
111
112
113
114
115
116
117
118
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top